Sharps Technology Shares Surge More Than 50% Following $400 Million Investment in Solana Treasury
Investment Announcement: Sharps Technology Inc. plans to raise over $400 million through a private placement to establish a digital asset treasury focused on Solana, with shares increasing by 54.18% following the announcement.
Transaction Details: The private investment in public equity is priced at $6.50 per unit, including warrants for three years, and is expected to close around August 28, 2025, backed by notable firms like ParaFi and Pantera.
Strategic Vision: New CIO Alice Zhang emphasized Solana's efficient infrastructure for global market adoption, while executive chairman Paul K. Danner highlighted the company's partnerships positioning it as a leader in Solana-focused investments.
Solana's Growth: The Solana network is experiencing rapid expansion, with significant developer growth, substantial app revenue, and high trading volumes, solidifying its status as one of the most liquid digital assets globally.
Trade with 70% Backtested Accuracy
Analyst Views on STSS
About STSS
About the author
Biotech Surge Post-Market: Inspira, MediciNova, and DiaMedica Therapeutics Among Top Performers
Biotech Stocks Performance: Several small-cap biotech and healthcare companies saw notable gains in after-hours trading, driven by recent corporate updates and clinical milestones.
Inspira Technologies Update: Inspira Technologies Oxy B.H.N. Ltd. rose 5.88% following a recent agreement for a registered direct offering and a Standby Equity Purchase Agreement, despite no new news on the day.
MediciNova's Clinical Trial Success: MediciNova, Inc. advanced 4.83% after successfully completing patient enrollment in its Phase 2 OXTOX study, which evaluates MN-166 for preventing chemotherapy-induced peripheral neuropathy.
DiaMedica's FDA Meeting: DiaMedica Therapeutics Inc. gained 2.89% after a productive pre-IND meeting with the FDA regarding its study of DM199 in preeclampsia, with an additional non-clinical study requested.
Sharps Technology to Enhance Solana Treasury Approach in Partnership with Coinbase
Collaboration with Coinbase: Sharps Technology is expanding its Solana digital asset treasury strategy through a strategic partnership with Coinbase Global, utilizing Coinbase Prime's custody and OTC desk services.
Acquisition of SOL: The company has acquired over 2 million SOL, valued at over $400 million, with the cryptocurrency currently trading above $210.
Sharps Technology Expands Digital Asset Treasury Strategy with Coinbase
Strategic Collaboration: Sharps Technology, Inc. has partnered with Coinbase to enhance its Solana digital asset treasury strategy, having acquired over 2 million SOL valued at over $400 million.
Utilization of Coinbase Services: The collaboration will leverage Coinbase's custody infrastructure and OTC desk products, aiming to support the global adoption of digital assets while ensuring secure and regulated service.
Sharps Technology Initiates $100 Million Stock Buyback Program; Shares Rise in Pre-market Trading
Stock Repurchase Program: Sharps Technology, Inc. has authorized a stock repurchase program to buy back up to $100 million of its outstanding common stock, aiming to enhance shareholder value and manage its capital structure.
Market Reaction: Following the announcement, Sharps Technology's stock rose by 8.41% in pre-market trading, reaching $7.35 on the Nasdaq.
Sharps Technology Approves $100 Million Stock Repurchase Plan
Stock Repurchase Program: Sharps Technology (NASDAQ: STSS) has launched a stock repurchase program to buy back up to $100 million of its common stock, which is approximately 55.5% of its market cap of $180.35 million as of October 1, 2025.
Market Reaction: Following the announcement, shares of STSS increased by 1.92% in premarket trading on Thursday.
Sharps Technology Announces $100 Million Stock Repurchase Program
Stock Repurchase Program: Sharps Technology, Inc. announced a stock repurchase program to buy back up to $100 million of its outstanding common stock, aimed at enhancing shareholder value and demonstrating confidence in the company's growth prospects.
Digital Asset Strategy: The company has also initiated a digital asset treasury strategy, acquiring over 2 million SOL, the native digital asset of the Solana blockchain, to leverage capital markets for on-chain yield generation.
Biotech Surge Post-Market: Inspira, MediciNova, and DiaMedica Therapeutics Among Top Performers
Biotech Stocks Performance: Several small-cap biotech and healthcare companies saw notable gains in after-hours trading, driven by recent corporate updates and clinical milestones.
Inspira Technologies Update: Inspira Technologies Oxy B.H.N. Ltd. rose 5.88% following a recent agreement for a registered direct offering and a Standby Equity Purchase Agreement, despite no new news on the day.
MediciNova's Clinical Trial Success: MediciNova, Inc. advanced 4.83% after successfully completing patient enrollment in its Phase 2 OXTOX study, which evaluates MN-166 for preventing chemotherapy-induced peripheral neuropathy.
DiaMedica's FDA Meeting: DiaMedica Therapeutics Inc. gained 2.89% after a productive pre-IND meeting with the FDA regarding its study of DM199 in preeclampsia, with an additional non-clinical study requested.
Sharps Technology to Enhance Solana Treasury Approach in Partnership with Coinbase
Collaboration with Coinbase: Sharps Technology is expanding its Solana digital asset treasury strategy through a strategic partnership with Coinbase Global, utilizing Coinbase Prime's custody and OTC desk services.
Acquisition of SOL: The company has acquired over 2 million SOL, valued at over $400 million, with the cryptocurrency currently trading above $210.
Sharps Technology Expands Digital Asset Treasury Strategy with Coinbase
Strategic Collaboration: Sharps Technology, Inc. has partnered with Coinbase to enhance its Solana digital asset treasury strategy, having acquired over 2 million SOL valued at over $400 million.
Utilization of Coinbase Services: The collaboration will leverage Coinbase's custody infrastructure and OTC desk products, aiming to support the global adoption of digital assets while ensuring secure and regulated service.
Sharps Technology Initiates $100 Million Stock Buyback Program; Shares Rise in Pre-market Trading
Stock Repurchase Program: Sharps Technology, Inc. has authorized a stock repurchase program to buy back up to $100 million of its outstanding common stock, aiming to enhance shareholder value and manage its capital structure.
Market Reaction: Following the announcement, Sharps Technology's stock rose by 8.41% in pre-market trading, reaching $7.35 on the Nasdaq.
Sharps Technology Approves $100 Million Stock Repurchase Plan
Stock Repurchase Program: Sharps Technology (NASDAQ: STSS) has launched a stock repurchase program to buy back up to $100 million of its common stock, which is approximately 55.5% of its market cap of $180.35 million as of October 1, 2025.
Market Reaction: Following the announcement, shares of STSS increased by 1.92% in premarket trading on Thursday.
Sharps Technology Announces $100 Million Stock Repurchase Program
Stock Repurchase Program: Sharps Technology, Inc. announced a stock repurchase program to buy back up to $100 million of its outstanding common stock, aimed at enhancing shareholder value and demonstrating confidence in the company's growth prospects.
Digital Asset Strategy: The company has also initiated a digital asset treasury strategy, acquiring over 2 million SOL, the native digital asset of the Solana blockchain, to leverage capital markets for on-chain yield generation.
